Learning Objectives:

  1. Explain guidelines for additional therapies for patients on maximally tolerated statin therapy.
  2. Understand the pathogenesis of lipid metabolism and ASCVD.
  3. Recognize the undertreatment of lipid disorders in patients with PAD
Session date: 
06/30/2022 - 7:30am to 8:30am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael Davidson, MD